Volume 8, Number 8, August 2002

Research

DNA Vaccine Expressing Conserved Influenza Virus Proteins Protective against H5N1 Challenge Infection in Mice

Suzanne L. Epstein,* Terrence M. Tumpey,† Julia A. Misplon,* Chia-Yun Lo,* Lynn A. Cooper, ‡ Kanta Subbarao,‡ Mary Renshaw,‡ Suryaprakash Sambhara,‡ and Jacqueline M. Katz‡
*Food and Drug Administration Rockville, Maryland, USA; †United States Department of Agriculture, Athens, Georgia, USA; and ‡Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Figure 2. Mice immunized with influenza A nucleoprotein and matrix DNA (A/NP+A/M DNA) are protected against lethal A/Hong Kong/156/97 (HK/156) challenge. Mice were vaccinated as in Figure 1 with A/NP+A/M DNA, with influenza B nucleoprotein DNA (B/NP+blank DNA), or with 100 mouse infectious dose (MID)₅₀  of  influenza A/Puerto Rico8/34 (A/PR/8) live virus. Sixteen days after the last dose of DNA, mice were challenged with 10,000 MID₅₀ of HK/156/97 intranasally. a. Monitoring of morbidity by body weight loss. b. Viral titers of lung and brain homogenates. Each bar represents the result for one mouse. Dashed lines indicate detection limits. Compared to the B/NP DNA controls, lung titers were significantly reduced in the A/NP+A/M DNA group (p=0.001, analysis of variation (ANOVA)) and the A/PR/8 group (p<0.001, ANOVA). c. Survival after challenge with HK/156.  d. Survival after rechallenge with 100 MID₅₀ of HK/483 of mice primed with A/NP+A/M DNA and which had all survived the previous HK/156 infection.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed July 9, 2002

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention